Index

• Abeokuta HF Registry Cohort, Nigeria, predictors of rehospitalization in
  • cost analyses
  • estimation of indirect costs
  • health care expenditure
  • inpatient and outpatient care cost
  • patient enrollment
  • specific costs
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • total costs
• Abeokuta, Nigeria, AHF in
  • cohort profile
  • echocardiography
  • etiology of HF
  • outcomes
  • patients’ demographic and clinical characteristics
  • pharmacotherapy
  • precipitating factors for AHF and-lead ECG
  • signs of AHF
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• Abuja Heart Society, hypertensive HF in
• ACCESS registry
  • case fatality
  • management
  • patients’ baseline characteristics
  • post-hospital management
  • study aims
  • study findings
  • study interpretation
  • study limitations
  • study methods
• ACE inhibitor
• acquired heart disease
  • in Malawi
  • protection
  • in Zimbabwe
  • see also endomyocardial fibrosis; rheumatic heart disease
• acquired immune deficiency syndrome see HIV/AIDS
• ACS see acute coronary syndrome
• Acute Coronary Events—a Multinational Survey of Current Management Strategies see ACCESS registry
• acute coronary syndrome
  • see also ACCESS registry
• acute coronary syndrome in HIV infection
  • angiographic follow-up
  • clinical and demographic characteristics and HIV status
  • clinical outcomes
  • coronary intervention
  • initial angiographic features
  • study aims
  • study background
  • study definitions
  • study design and patient enrollment
  • study findings
  • study interpretation
  • study limitations
• acute coronary syndrome in HIV infection, thrombotic profile
  • clinical profile and thrombotic profile
  • HIV-positive clinical and thrombotic profile
  • patient enrollment and thrombophilic screening
  • platelet studies
  • study aims
  • study background
  • study interpretation
  • study limitations
  • study method
• acute heart failure (AHF)
  • in Abeokuta, Nigeria
  • see also under THESUS-HF
• acute rheumatic fever and RHD, prevention
  • 7-strategy Markov decision analysis cohort model
  • costs, cost-effectiveness, and incremental effects of strategies
  • sensitivity analysis
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• acute rheumatic fever with pancarditis
• adolescent heart disease, vertically acquired HIV infection and
• African INTERHEART Study
  • cohort profile
  • cumulative effects of risk factors
  • ethnic differences
  • patient enrollment and data collection
  • pattern of risk associated with de novo AMI
  • patterns of risk factor for AMI, sex and
  • population-attributable risks
  • study interpretation
  • study limitations
• AHF see acute heart failure
• alcohol intake
• acute myocardial infarction
  • see also African INTERHEART Study
• angina
  • unstable
• antiretroviral therapy
  • see also HAART
• aortic stenosis
• apolipoprotein B, ethnic differences in
• apolipoprotein B/apolipoprotein A-1 ratio
• aspirin
• atrial fibrillation
  • in Soweto
• atrial septal defect
• atrioventricular septal defect

• beta blocker
• bromocriptine, evaluation in PPCMO
  • baseline and-month echocardiographic parameters
  • natriuretic peptide levels
  • outcomes and infant findings
  • patient enrollment
  • patients’ demographic and clinical characteristics
  • pharmacotherapy
  • study interpretation
  • study limitations

• calcium channel antagonist
• Cameroon, Republic of
  • chronic HF in adults treated for hypertension
  • demography
• Cameroon, Republic of, congenital heart disease in
  • patient enrollment
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • surgical and postsurgical management
  • transthoracic Doppler-echocardiography presentations
• Cape Town, demography
• cardiac tamponade
• cardiomyopathy (CMO)
  • dilated
  • HIV-related
  • hypertrophic
  • peripartum see PPCMO
• cardiovascular risk
  • antecedent risk
  • primary care perspective
  • hypertension in Nigeria
  • in Soweto
• Cardiovascular Risk in Black South Africans (CRIBSA) Study
• carvedilol
• cathepsin D
• CHD see congenital heart disease
• chronic heart failure, in adults treated for hypertension, in Cameroon
  • comorbidities
  • patient enrollment
  • patients’ demographic and clinical characteristics
  • pharmacological management
  • risk factors
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• chronic obstructive pulmonary disease (COPD)
• clopidogrel
• CMO see cardiomyopathy
• coarctation of the aorta
• congenital heart disease (CHD)
  • in Cameroon
  • epidemiology
  • in Mozambique
• congestive heart failure (CHF)
• constrictive pericarditis
• cor pulmonale
• coronary artery disease (CAD)
• coronary atherosclerosis, chronic
• CRIBSA Study
• cyanosis

• diabetes, type
• digoxin
• dilated CMO
  • gender and
  • heart failure and
  • HIV-related
• double outlet right ventricle
• Duchenne muscular dystrophy

• EMF see endomyocardial fibrosis
• enalapril
• endomyocardial fibrosis (EMF)
  • in Mozambique
• erythromycin

• fixed pulmonary hypertension
• Fulani group
• furosemide

• Global Rheumatic Heart Disease Registry (REMEDY)

• HAART
  • CAD and
  • HIV and
• Hausa group
• Health Education (HEDU) Initiative
• heart failure (HF)
  • geographical context
  • incidence
  • major causes
  • see also acute heart failure; hypertensive heart failure
• heart failure with preserved ejection fraction (HFpEF)
• heart failure with reduced ejection fraction (HFrEF)
• Heart of Soweto Study
  • atrial fibrillation in
  • classification of case presentations
  • cohort profile
  • communicable and noncommunicable forms of heart disease
  • diagnostic classifications
  • ethnicity, HF and
  • gender, HF and
  • HF in
  • hypertension and hypertensive heart disease
  • initial findings
  • patient enrollment
  • patient profiling
  • RHF in
  • spectrum of risk and disease
  • STROBE guidelines
  • study background
  • study findings
  • study limitations
  • study timeline
• hemorrhagic stroke
• highly active antiretroviral therapy see HAART
• HIV/AIDS
  • acute coronary syndrome in
  • acute coronary syndrome in, thrombotic profile
  • in adolescence
  • incidence
  • TB inflammation in
• HIV-related CMO demographic and clinical characteristics
• HIV-related dilated CMO
• HIV-related heart disease
  • HAART and
  • study limitations
  • in urban African community
• HIV-related pulmonary arterial hypertension (PAH)
• Hurler syndrome
• hypertensive heart failure
  • BP profile and management
  • cardiac function
  • comorbidities
  • demographic and clinical characteristics
  • hypertensive HF
  • patient enrollment
  • study aims
  • study background
  • study interpretation
  • study limitations
  • study methods
• hypertensive heart failure in Abuja Heart Society
  • patient enrollment
  • patients’ demographic and clinical characteristics
  • pattern of HF
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • vs Heart of Soweto Study
• hypertensive heart failure in Nigerian Africans
  • 12-lead ECG and echocardiography findings
  • health outcomes
  • patients’ demographic and clinical characteristics
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • treatment patterns
• hypertrophic cardiomyopathy
• hypocalcemia

• Igbo groups
• immune reconstitution inflammatory syndrome
• infant and childhood heart disease
  • demographics and pediatric cardiovascular care service availability
  • geographical context
  • protection of heart health
• infectious heart disease in Africa
  • geographical context
  • history and contemporary burden
• infective endocarditis
• Investigation of the Management of Pericarditis (IMPI)
• ischemic heart disease (IHD)
  • heart failure and
• ischemic stroke

• Kaposi's sarcoma

• left ventricular hypertrophy (LVH)
• loop diuretics
• low-density lipoprotein (LDL) cholesterol, ethnic differences

• malaria
• Malawi, pediatric cardiac disease in
  • demography
  • patient enrollment
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
• Maputo, Mozambique, stroke in
  • data collection
  • demographics
  • infant and child mortality
  • life expectancy in
  • patient enrollment
  • patient prehospital characteristics
  • short-term stroke-related case fatality
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
• Marfan syndrome
• maternal cardiac disease in South Africa
  • fetal outcome
  • maternal outcome
  • patients demography and clinical characteristics
  • referral algorithm
• maternal mortality
  • South Africa
• mitral valve prolapse
• mitral valve regurgitation
• Mozambique, coronary heart disease in
  • classification
  • complications
  • demography
  • incidence
  • patient enrollment
  • study aims
  • study findings
  • study interpretation
  • study limitations
  • surgical procedures
• Mozambique, endomyocardial fibrosis in
  • clinical profiling
  • criteria for diagnosis and assessment
  • patient enrollment
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
• Mycobacterium indicus pranii in tuberculous pericarditis
• myocardial infarction (MI)
  • acute (AMI)
  • see also African INTERHEART Study
• myocardial necrosis
• myocarditis, acute
• myxomatous mitral valve

• Nigeria, hypertension and cardiovascular risk in
  • anthropometry and BP measurement
  • correlates if hypertension
  • demographic and clinical characteristics
  • patient enrollment
  • prevalence of hypertension
  • study aims
  • study background
  • study interpretation
  • study limitations
• Nigeria, major causes of heart failure in
  • see also Abeokuta, Nigeria; Nigeria, hypertension and cardiovascular risk in
• noncommunicable diseases
• noncompacted left ventricle
• non-ST segment elevation myocardial infarction (NSTEMI)
• nutritional cardiomyopathies

• obesity
  • abdominal
  • acute heart failure and
  • CVD risk and
  • hypertension and
  • stroke and
  • in women
• ostium primum atrial septal defect
• ostium secundum atrial septal defect

• Pan African Pulmonary Hypertension Cohort (PAPUCO) study
  • country participation in
  • definition of pulmonary hypertension
  • diagnostic algorithm and data collection in
  • patient enrollment
  • research platform
  • study aim and objectives
  • study design and setting
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • WHO classification for pulmonary hypertension
• patent ductus arteriosus
• penicillin
  • in acute rheumatic fever
  • in pharyngitis
• pericarditis
  • acute
  • classification
  • constrictive
  • effusive constrictive
  • effusive
  • pneumococcal
  • see also tuberculous pericarditis
• peripartum cardiomyopathy see PPCMO
• pneumococcal pericarditis
• polycythemia
• postpericardectomy syndrome
• PPCMO
  • mechanisms underlying
• PPCMO, health outcomes in S. Africa
  • cohort profile
  • patient enrollment
  • patients’ baseline and follow-up
  • study interpretation
  • study limitations
• prednisolone in tuberculous pericarditis
• pregnancy, valvular heart disease in
  • maternal cardiac disease in South Africa
  • see also PPCMO
• primary care, CVD risk and
  • advanced cardiac assessment
  • advanced cardiac profiling
  • CVD risk profile
  • demographic and clinical characteristics
  • patient enrollment
  • study aims
  • study interpretation
  • study limitations
  • study methods
• pulmonary arterial hypertension (PAH), HIV-related
• pulmonary atresia
• pulmonary hypertension
  • fixed
  • HIV and
  • left ventricular dysfunction and
  • right ventricle dilatation and
  • secondary
  • WHO classification for
  • see also Pan African Pulmonary Hypertension Cohort (PAPUCO) study
• pulmonary stenosis
• pulmonary vascular obstructive disease

• REMEDY Registry of RHD
  • cohort profile
  • patient enrollment
  • pattern and severity of native valve disease, secondary prophylaxis and
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
• retinopathy
• RHD see rheumatic heart disease
• rheumatic heart disease (RHD)
  • estimated incidence
  • gender and structural valve disease
  • newly diagnosed RHD patients
  • newly diagnosed valvular heart disease
  • outcomes
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• rifampin
• right heart failure (RHF)
  • see also Heart of Soweto Study; Pan African Pulmonary Hypertension Cohort (PAPUCO) study

• SABPA Study
• schistosomiasis
• Seychelles, stroke mortality reduction rate in
• smoking
  • acute coronary syndrome and
  • cardiovascular risk and
  • CVD risk and
  • heart failure and
  • HIV and
  • HIV-related dilated CMO and
  • hypertensive heart failure and
  • stroke and
• Soweto, Heart Awareness Days in
  • demographic and risk factor characteristics
  • demography
  • obesity and
  • patient enrollment
  • pattern of risk for future heart disease
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
  • systolic and diastolic BP
  • see also Heart of Soweto Study
• spironolactone
• ST segment elevation myocardial infarction (STEMI)
• statin
• STEPS Stroke survey
• Streptococcus pharyngitis, Group B
• STROBE
• stroke
  • future improvements in outcome
  • hemorrhagic
  • incidence
  • ischemic
  • in Maputo, Mozambique
• subaortic aneurysm
• submitral aneurysm
• Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA)

• Takayasu disease
• TB see tuberculosis
• Tetralogy of Fallot
• The Sub-Saharan Africa Survey of Heart Failure see THESUS-HF
• THESUS-HF
  • causes and therapies
  • patient enrollment
  • patient follow-up and outcomes
  • patients’ demographic and clinical characteristics
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• THESUS-HF, ECG abnormalities in
  • 12-lead ECG findings
  • health outcomes according to ECG findings
  • predictors of mortality
  • study aims
  • study background
  • study design and clinical setting
  • study findings
  • study interpretation
  • study limitations
• THESUS-HF, gender differences in AHF presentations
  • cardiac function
  • health outcomes
  • study aims
  • study background
  • study findings
  • study interpretation
  • study limitations
  • study methods
• THUSA Study
• transient ischemic attack (TIA)
• Transition and Health during Urbanisation of South Africans (THUSA)
• transposition of great arteries, congenitally corrected
• tricuspid atresia
• tuberculosis (TB)
• tuberculous pericarditis
• tuberculous pericarditis, prednisolone and Mycobacterium indicus pranii in
  • cancer and
  • HAART, use of
  • Mycobacterium indicus pranii vs placebo
  • outcomes and statistical analysis
  • patient enrollment
  • prednisolone comparison
  • study interpretation
  • study limitations
  • study methods
  • study population
  • study procedures
  • treatment regimens and adherence
  • trial study design

• unstable angina

• valvular heart disease (VHD)
• ventricular septal defect
• vitamin D deficiency

• warfarin
• Wolf-Parkinson-White Syndrome

• Yoruba group

• Zimbabwe, adolescent heart disease and vertically acquired HIV infection in
  • demographic and clinical characteristics
  • demography
  • LV diastolic dysfunction and hypertrophy
  • LV systolic impairment and dilatation
  • patient enrollment
  • pulmonary hypertension and RV dilatation
  • study aims
  • study background
  • study interpretation
  • study limitations